Kerry Horgan
- Hepatology top 2%
- Oncology top 10%
- Pathology and Forensic Medicine top 5%
- Molecular Biology
- Surgery
- Co-authors
- Andrew X. ZhuAlona MuzikanskyPankaj BhargavaKeith StuartLawrence S. BlaszkowskyPeter C. EnzingerDavid P. RyanJeffrey W. Clark
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (5 papers)Colorectal Cancer Treatments and Studies (4 papers)HER2/EGFR in Cancer Research (3 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Kerry Horgan
13 papers receiving 946 citations
Peers
Comparison fields: 5 of 55
- Hepatology 470
- Oncology 353
- Pathology and Forensic Medicine 276
- Molecular Biology 257
- Surgery 250
Countries citing papers authored by Kerry Horgan
This map shows the geographic impact of Kerry Horgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerry Horgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerry Horgan more than expected).
Fields of papers citing papers by Kerry Horgan
This network shows the impact of papers produced by Kerry Horgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerry Horgan. The network helps show where Kerry Horgan may publish in the future.
Co-authorship network of co-authors of Kerry Horgan
This figure shows the co-authorship network connecting the top 25 collaborators of Kerry Horgan. A scholar is included among the top collaborators of Kerry Horgan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kerry Horgan. Kerry Horgan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 48 | |
| 2 | 20 | |
| 3 | 2 | |
| 4 | 10 | |
| 5 | 9 | |
| 6 | 6 | |
| 7 | Randomized open-label phase 2 study of MM-111 and paclitaxel (PTX) with trastuzumab (TRAS) in patients with HER2-expressing carcinomas of the distal esophagus, gastroesophageal (GE) junction, and stomach who have failed front-line metastatic or locally ad | 1 |
| 8 | 229 | |
| 9 | 4 | |
| 10 | 132 | |
| 11 | 190 | |
| 12 | 9 | |
| 13 | 302 |
About Kerry Horgan
Kerry Horgan is a scholar working on Hepatology, Oncology and Pulmonary and Respiratory Medicine, having authored 13 papers that have together received 962 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Hepatology (470 citations), Pathology and Forensic Medicine (276 citations) and Oncology (353 citations). Kerry Horgan has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Andrew X. Zhu, Alona Muzikansky, Pankaj Bhargava, Keith Stuart, Lawrence S. Blaszkowsky, Peter C. Enzinger, David P. Ryan, Jeffrey W. Clark, Susan Sheehan and Charles S. Fuchs. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.